Gillian Goldberg Bassirpour, MD in Aliso Viejo, CA - Allergy & Immunology

Gillian Goldberg Bassirpour, MD is a Allergy & Immunology - Allergy physician based in Aliso Viejo, California. Gillian Goldberg Bassirpour is licensed to practice in California (license number C174521) and her current practice location is 2 Journey Ste 201, Aliso Viejo, California. She can be reached at her office (for appointments etc.) via phone at (949) 287-4900.

NPI number for Gillian Goldberg Bassirpour is 1811216765 and her current mailing address is 2 Journey Ste 201, Aliso Viejo, California. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1811216765.

Contact Information

	Gillian Goldberg Bassirpour, MD
	2 Journey Ste 201, Aliso Viejo, CA 92656-3373
	(949) 287-4900
	Not Available

Physician's Profile

Full Name	Gillian Goldberg Bassirpour
Gender	Female
Speciality	Allergy & Immunology - Allergy
Location	2 Journey Ste 201, Aliso Viejo, California
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1811216765
Provider Enumeration Date: 05/18/2010
Last Update Date: 09/12/2023

Medical Identifiers

Medical identifiers for Gillian Goldberg Bassirpour such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1811216765	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207KA0200X	Allergy & Immunology - Allergy	C174521 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Gillian Goldberg Bassirpour is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Gillian Goldberg Bassirpour, MD 2 Journey Ste 201, Aliso Viejo, CA 92656-3373 Ph: (949) 287-4900	Gillian Goldberg Bassirpour, MD 2 Journey Ste 201, Aliso Viejo, CA 92656-3373 Ph: (949) 287-4900

News Archive

Tea Party Patriots and coalition partners to rally against government takeover of health care system

On the eve of the U.S. House of Representatives voting on a trillion-dollar government takeover of the health care system, the Tea Party Patriots will gather with coalition partners Americans for Tax Reform, FreedomWorks, Faith and Freedom Coalition, Institute for Liberty, Let Freedom Ring, 60 Plus, and many more to voice the concerns of millions of Americans.

Cerecor obtains exclusive, worldwide rights to NR2B receptor antagonist from Merck

Cerecor Inc, a neuroscience biotech company that develops therapies that have the potential to make a difference in diseases with high unmet medical needs, today announced that it has acquired exclusive, worldwide rights from Merck, known as MSD outside the United States and Canada, to develop and commercialize MK-0657, a small molecule NMDA receptor subunit 2B (NR2B) antagonist for all human indications, including depression.

Viewpoints on health law: Concerns about 'Lake Wobegon-ization' of Medicare Advantage; Romney's efforts to raise fears

One of the significant reforms in the health-care law was to put private Medicare plans on a more equal footing with the traditional government program. ... But the immediate sting of the cuts was significantly lessened by the Obama administration's move to expand and speed up a program to pay bonuses to high-performing programs.

Brain-somatic-activating mutations in MTOR cause focal cortical dysplasia type II

Epilepsy is a brain disorder that afflicts more than 50 million people worldwide. Many epilepsy patients can control their symptoms through medication, but about 30% suffer from intractable epilepsy and are unable to manage the disease with drugs. Intractable epilepsy causes multiple seizures, permanent mental, physical, and developmental disabilities, and even death.

Existing anti-stroke drug can be effective in treating middle-ear infections

An existing anti-stroke drug is an effective treatment for middle-ear infections, showing the ability to suppress mucus overproduction, improve bacterial clearance and reduce hearing loss, according to researchers at Georgia State University and the University of Rochester.

Gillian Goldberg Bassirpour, MD - Allergy & Immunology in Aliso Viejo, CA